Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

How to set trading alerts

Bell Direct
March 1, 2017

How to transfer your shares to Bell Direct

Bell Direct
February 27, 2017

How to get a stock quote

Bell Direct
February 27, 2017

February newsletter Julia’s insights

Julia Lee
February 24, 2017

CEO interview – Cobalt Blue

Bell Direct
February 21, 2017

Your Money Your Call

Julia Lee
February 14, 2017

Your Money Your Call

Julia Lee
February 7, 2017

January review

Julia Lee
January 27, 2017

Superannuation Reforms

Bell Direct
January 16, 2017